ESMO Virtual Preceptorship on Head and Neck Cancer 2020
- Start date
- 11 Dec 2020
- End date
- 12 Dec 2020
- Location
- Virtual, CET Time
Learning objectives
- To understand epidemiology, aetiology and molecular biology of Head and Neck Squamous Cell Carcinoma (HNSCC)
- To understand multidisciplinary management and treatment of head and neck cancer
- To learn about advances in the treatment and novel targets in head and neck cancer
- To learn about salivary gland cancer
Accreditation
The programme of this virtual event has been accredited with 5 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Viktor Grünwald, Germany
- Jean-Pascal Machiels, Belgium
Supported by
